GC Biopharma stock price
녹십자KRX:006280 · KOSPI · HealthcareToday's signals · VCP, MACD bullish cross
Signal details →GC Biopharma last closed at ₩125,800 (-2.71%) on 2026-10-02. Signals today: VCP, MACD bullish cross. Listed on KOSPI. Trailing 12 months PER is -28.8×. Its overall grade ranks 196 of 306 stocks in Healthcare.
About this company
GC Biopharma last closed at ₩125,800 (-2.71%) on 2026-10-02. Signals today: VCP, MACD bullish cross. Listed on KOSPI.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 196/306
Valuation grade B-
Dividends
2025 dividend per share · ₩1,500 · Yield 1.22%
Details →Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- GC PharmaCompetitor
혈액제제·백신·바이오의약품 분야에서 같은 계열 사업을 영위하는 국내 주요 경쟁사
- SK바이오사이언스Competitor
백신 개발·위탁생산(CMO) 분야의 국내 경쟁사
- 한미약품Competitor
전문의약품 중심의 국내 대형 제약사로 처방약 시장에서 경쟁
ETFs holding this stock
TIGER 200 헬스케어
Details →About GC Biopharma
- What technical signals does GC Biopharma (006280) have?
- GC Biopharma current technical signals: VCP, MACD bullish cross.
- Is GC Biopharma a cup-and-handle pattern?
- No. GC Biopharma has no valid Cup signal right now.
- What published figures are available for GC Biopharma?
- Market cap: KRW 1.5T. Trailing 12 months PER: -28.8×. Latest quarter PBR: 1.16×. Dividend yield: 1.22%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about GC Biopharma, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).